10-K · May 8, 2026
DXC Technology's 2026 10-K reflects a challenging year with total revenues declining 1.8% to $12.64 billion and a significant drop in diluted EPS to $0.10 from $2.10 in 2025. Key segments showed varied performance, with…
Earnings analysis · 10-Q
Filed October 30, 2026 · Our reading of the company's report
The latest report
DXC reported a mixed quarter: revenue of $3.034 billion and non-GAAP diluted EPS of $0.67 exceeded consensus, but GAAP diluted EPS was only $0.15. Insurance grew 23.1%, while GIS revenue and bookings each fell 10.0%,…
DXC reported a mixed quarter: revenue of $3.034 billion and non-GAAP diluted EPS of $0.67 exceeded consensus, but GAAP diluted EPS was only $0.15. Insurance grew 23.1%, while GIS revenue and bookings each fell 10.0%, leaving the core operating trajectory under pressure. The filing reported effective controls and no material changes to the risk factors, while the associated outlook called for FY27 revenue of $11.91 billion-$11.98 billion and non-GAAP EPS of $2.25-$2.50.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Revenue was $3.034 billion, 1.31% above the $2.9948 billion consensus estimate. Non-GAAP diluted EPS was $0.67, versus the $0.55 estimate.
Insurance revenue increased 23.1% year over year, making it the strongest reported growth area in the quarter.
The company repurchased 2,025,999 shares in July, 1,840,450 in August and 1,796,305 in September 2026, totaling 5,662,754 shares during the quarter.
Approximately $212 million remained available under the share-repurchase authorization as of September 30, 2026.
Management concluded that disclosure controls and procedures were effective as of September 30, 2026, and reported no changes in internal control that materially affected, or were reasonably likely to materially affect, reporting.
GIS revenue declined 10.0% year over year and bookings declined 10.0%, indicating continued pressure in the company’s core business despite Insurance growth of 23.1%.
GAAP diluted EPS was $0.15, substantially below the $0.55 estimate and well below the reported $0.67 non-GAAP diluted EPS, highlighting a significant gap between GAAP and adjusted profitability.
The 10-Q states that there were no material changes during the three months ended September 30, 2026 to the risk factors in the March 31, 2026 Form 10-K; therefore, existing risks remain applicable without a newly disclosed mitigating factor.
The associated earnings disclosure provided FY27 guidance of $11.91 billion-$11.98 billion of revenue, 5.75%-6.25% adjusted EBIT margin, $2.25-$2.50 non-GAAP diluted EPS and approximately $600 million of free cash flow. It also provided Q3 FY27 guidance of approximately $2.98 billion of revenue, 6.0% adjusted EBIT margin and $0.55 non-GAAP diluted EPS, but did not provide the prior outlook needed to determine whether guidance was raised, maintained or lowered.
DXC Technology's 2026 10-K reflects a challenging year with total revenues declining 1.8% to $12.64 billion and a significant drop in diluted EPS to $0.10 from $2.10 in 2025. Key segments showed varied performance, with…
DXC Technology reported Q3 FY2026 earnings with revenue of $3.19 billion, a modest decline of 1.0% compared to the previous year and a notable beat on EPS at $0.96, exceeding estimates by 14.3%. The results highlighted…
DXC Technology reported Q2 fiscal 2026 results with revenues of $3.16 billion, down 2.5% compared to a year ago. Despite a decrease in diluted EPS to $0.20 from $0.23, adjusted EPS rose to $0.84, exceeding estimates.…
DXC Technology reported disappointing first-quarter results for fiscal 2026, with a revenue drop to $3.16 billion, reflecting a 2.4% decrease year-over-year. Although EPS of $0.09 showed a significant drop from the…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.